Patent Assignment
Reel/Frame 028488/0019
Security Agreement
Recorded: 2012-06-29
Pages: 7
Assignor
ISTA PHARMACEUTICALS, INC.
Executed: 2012-06-29
Assignee
CITIBANK, N.A.
1615 BRETT ROAD, BUILDING III, NEW CASTLE, DELAWARE, 19720
Covered Properties
(7)
Ophthalmic Formulations and Uses Thereof
Bromfenac Ophthalmic Formulations and Methods of Use
Application:
11/755,662 →
Publication:
US 2007/0287749
Ophthalmic NSAIDS as Adjuvants
Application:
12/867,470 →
Publication:
US 2011/0054031
Bepotastine Compositions
Bepotastine Compositions
Application:
13/505,426 →
Publication:
US 2013/0046240
Bepotastine Compositions
Application:
13/505,438 →
Publication:
US 2012/0323178
Bromfenac Bioavailability
Application:
61/546,290 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →
Assignment of Assignor's Interest
Aug 15, 2013
From: ISTA PHARMACEUTICALS, LLC
To: BAUSCH & LOMB PHARMA HOLDINGS CORP.
Reel/Frame 031019/0937 →
Security Agreement
Nov 1, 2013
From: BAUSCH & LOMB PHARMA HOLDINGS CORP.
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031533/0859 →
Notice of Succession of Agency
Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
Security Interest
Jul 19, 2017
From: BAUSCH & LOMB PHARMA HOLDINGS CORP.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043046/0030 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Security Interest
Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Merger
Dec 4, 2019
From: RHC HOLDINGS, INC.; SIGHT SAVERS, INC.; B&L FINANCIAL HOLDINGS CORP.; BAUSCH & LOMB CHINA, INC.
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 051177/0793 →
Security Interest
Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
Security Agreement
Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
Patent Security Agreement
May 10, 2022
From: BAUSCH & LOMB INCORPORATED
To: CITIBANK, N.A. AS COLLATERAL AGENT
Reel/Frame 059913/0548 →
Release of Security Interest in Specified Patents (Reel/Frame 034749/0689)
Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; UNIVERSITY OF ROCHESTER
Reel/Frame 061778/0146 →
Release of Security Interest in Specified Patents (Reel/Frame 031533/0859)
Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061778/0306 →
Release of Security Interest in Specified Patents (Reel/Frame 045444/0299)
Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; PF CONSUMER HEALTHCARE 1 LLC
Reel/Frame 061779/0001 →
Omnibus Patent Security Release Agreement (Reel/Frame 043046/0030)
Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061874/0179 →
Omnibus Patent Security Release Agreement (Reel/Frame 059121/0001)
Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061873/0001 →
Omnibus Patent Security Release Agreement (Reel/Frame 056811/0814)
Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061872/0669 →
Omnibus Patent Security Release Agreement (Reel/Frame 048556/0758)
Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH COMPANIES INC.; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 061872/0484 →
Omnibus Patent Security Release Agreement (Reel/Frame 045444/0634)
Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; LABORATOIRE CHAUVIN S.A.S.; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 061872/0295 →
Omnibus Patent Security Release Agreement (Reel/Frame 043251/0932)
Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH
Reel/Frame 061872/0099 →
Assignment of Assignor's Interest
Feb 9, 2023
From: MCMULLIN, KIRK
To: ISTA PHARMACEUTICALS, INC.
Reel/Frame 062644/0265 →
Patent Security Agreement
Oct 4, 2023
From: BAUSCH & LOMB INCORPORATED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 065120/0086 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
Patent Security Agreement
Jul 1, 2025
From: BAUSCH & LOMB INCORPORATED; ALDEN OPTICAL LABORATORIES, INC.; BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 071773/0871 →